Status:
COMPLETED
A 7-year Follow up of All Subjects Incuded in Protocol 31GB0106
Lead Sponsor:
Galderma R&D
Conditions:
Breast Augmentation
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Several subjects included in a Pilot study (CTN 31GB0106) during 2002-2003 still had Macrolane deposits in the breast when the last study visit was performed. An additional follow up visit is planned ...
Detailed Description
All subjects included in a Pilot study between 2002-2003 (CTN 31GB0106) are offered to take part in a seven year safety follow up after the initial injection of the former formulation of Macrolane int...
Eligibility Criteria
Inclusion
- Participant in 31GB0601
Exclusion
- There are no exclusion citeria in this study
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01146275
Start Date
March 1 2010
End Date
August 1 2010
Last Update
September 28 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Akademikliniken Öresund
Malmo, Sweden, 21753
2
Sophiahemmet
Stockholm, Sweden, 11486
3
Akademikliniken
Stockholm, Sweden, 11542
4
ProForma Clinic
Stockholm, Sweden, 118 63